NEXTPHARMA LOGISTIC GMBH — Ezetimibe Importer Profile
Pharmaceutical Importer · #5 buyer for Ezetimibe · $539.7K import value · 12 shipments · GERMANY · DGFT Verified
NEXTPHARMA LOGISTIC GMBH is the #5 importer of Ezetimibe from India with $539.7K in import value and 12 verified shipments. NEXTPHARMA LOGISTIC GMBH holds a 0.2% market share in Ezetimibe imports based in GERMANY. The company sources from 1 verified supplier across 6 formulations shipped to 1 country.
NEXTPHARMA LOGISTIC GMBH — Ezetimibe Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ezetimibe to NEXTPHARMA LOGISTIC GMBH?
Verified from 12 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $539.7K | 12 | 100.0% |
NEXTPHARMA LOGISTIC GMBH sources Ezetimibe from 1 verified Indian supplier based on 12 customs records. The primary supplier is INTAS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does NEXTPHARMA LOGISTIC GMBH Compare to Nearest Ezetimibe Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 16 | APOTEX PTY LIMITED | AUSTRALIA | $1.3M | 25 | $50.0K |
| 19 | MARCAN PHARMACEUTICALS INC., | CANADA | $1.1M | 54 | $20.0K |
| 5 | NEXTPHARMA LOGISTIC GMBH ★ | GERMANY | $600.0K | 12 | $50.0K |
| 12 | LEK D.D | SLOVENIA | $600.0K | 12 | $50.0K |
| 14 | CSP MYLAN SAS AT CSP LABO 274 | FRANCE | $600.0K | 12 | $50.0K |
NEXTPHARMA LOGISTIC GMBH ranks #5 among 466 Ezetimibe importers from India. Average shipment value of $50.0K compared to the market average of $112.5K. The closest competitors by value are APOTEX PTY LIMITED and MARCAN PHARMACEUTICALS INC.,.
Where Does NEXTPHARMA LOGISTIC GMBH Import Ezetimibe To?
Destination countries from 12 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $539.7K | 12 | 100.0% |
NEXTPHARMA LOGISTIC GMBH imports Ezetimibe to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $539.7K.
What Ezetimibe Formulations Does NEXTPHARMA LOGISTIC GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| EZETIMIB EZE. 10MG EACH TABLET CONTAINSEZETIMIBE 10 MG DETAILS AS PER INVOICE | $155.4K | 4 |
| PHARMACEUTICAL DRUGS AND MEDICINE : EZETIMIB EZE. 10MG EACH TABLET CONTAINS:EZETIMIBE 10 MG Net Wt.- 909.510 Kg. | $100.0K | 2 |
| PHARMACEUTICAL DRUGS AND MEDICINE : EZETIMIB EZE. 10MG EACH TABLET CONTAINS:EZETIMIBE 10 MG Net Wt.- 806.640 Kg. | $100.0K | 2 |
| PHARMACEUTICAL DRUGS AND MEDICINE : EZETIMIB EZE. 10MG EACH TABLET CONTAINS:EZETIMIBE 10 MG Net Wt.- 333.270 Kg. | $84.3K | 2 |
| PHARMACEUTICAL DRUGS AND MEDICINE-EZETIMIB EZE. 10MG EACH TABLET CONTAINS: EZETIMIBE 10 MG | $50.0K | 1 |
| PH.DRU.& MED.: EZETIMIB EZE. 10MG TABLETS (EACH TABLET CONTAINS: EZETIMIBE 10MG)[10X10T PER PACK] | $50.0K | 1 |
NEXTPHARMA LOGISTIC GMBH imports 6 distinct Ezetimibe formulations from India. The top formulation is EZETIMIB EZE. 10MG EACH TABLET CONTAINSEZETIMIBE 10 MG DETAI with 4 shipments worth $155.4K.
Regulatory Requirements: Importing Ezetimibe into Germany
What NEXTPHARMA LOGISTIC GMBH and other importers must comply with to import Ezetimibe from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Ezetimibe
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ezetimibe from India and How Much Does NEXTPHARMA LOGISTIC GMBH Import?
India exported $52.4M worth of Ezetimibe through 5,033 shipments from 169 suppliers to 85 countries, serving 466 buyers globally. NEXTPHARMA LOGISTIC GMBH imports $539.7K of this total, accounting for 0.2% of India's Ezetimibe exports with 12 shipments from GERMANY. This is verified from 12 customs shipment records covering 6 distinct formulations.
What Is the Average Order Value for NEXTPHARMA LOGISTIC GMBH's Ezetimibe Imports?
NEXTPHARMA LOGISTIC GMBH's average Ezetimibe order value is $45.0K per consignment, based on 12 shipments totaling $539.7K. NEXTPHARMA LOGISTIC GMBH is based in GERMANY and ranks #5 among all Ezetimibe importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ezetimibe to NEXTPHARMA LOGISTIC GMBH?
NEXTPHARMA LOGISTIC GMBH sources Ezetimibe from 1 verified Indian supplier: INTAS PHARMACEUTICALS LIMITED ($539.7K, 100.0%). This is based on 12 customs records.
How Does NEXTPHARMA LOGISTIC GMBH Compare to Other Ezetimibe Importers?
NEXTPHARMA LOGISTIC GMBH ranks #5 among 466 Ezetimibe importers from India with a 0.2% market share. The top 3 importers are BGP PRODUCTS GMBH ($16.4M), DAIICHI SANKYO EUROPE GMBH ($10.1M), ASCEND LABORATORIES,LLC ($6.7M). NEXTPHARMA LOGISTIC GMBH processed 12 shipments from GERMANY.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ezetimibe — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ezetimibe shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: NEXTPHARMA LOGISTIC GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as NEXTPHARMA LOGISTIC GMBH's capped import value divided by total capped export value for Ezetimibe across all Indian exporters.
- 5.Verified Records: This page is backed by 12 individual customs records matching NEXTPHARMA LOGISTIC GMBH importing Ezetimibe, covering 6 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 85+ countries, 466+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ezetimibe Import Data for NEXTPHARMA LOGISTIC GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for NEXTPHARMA LOGISTIC GMBH's Ezetimibe imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
NEXTPHARMA LOGISTIC GMBH
Company Profile
Multiple products · $0 total trade · Multiple categories
NEXTPHARMA LOGISTIC GMBH × Ezetimibe
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for NEXTPHARMA LOGISTIC GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ezetimibe. For current order-level data, contact TransData Nexus.